The health and economic impact of scaling cervical cancer prevention in 50 low- and lower-middle-income countries

World Population Prospects The 2006 Revision

Zlotnik, H. (2007) · United Nations eBooks · Cited by 7,896 · see citing works

Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions

The FUTURE II Study Group (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,056 · see citing works

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women

Paavonen, J., Naud, P., Salmerón, J., Wheeler, C., Chow, S.-N., Apter, D., Kitchener, H., Castellsague, X., Teixeira, J., Skinner, Sr., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61248-4 · Cited by 1,655 · see citing works

A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women

Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433 · see citing works

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

Li, N., Franceschi, S., Howell‐Jones, R., Snijders, P. J. F., & Clifford, G. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25396 · Cited by 1,067 · see citing works

Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

Bruni, L., Díaz, M., Barrionuevo-Rosas, L., Herrero, R., Bray, F., Bosch, F. X., de Sanjosé, S., & Castellsagué, X. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30099-7 · Cited by 827 · see citing works

Macroeconomics and health : investing in health for economic development : report of the Commission on Macroeconomics and Health

Sachs, J. D. (2001) · World Health Organization eBooks · Cited by 800 · see citing works

Expansion of cancer care and control in countries of low and middle income: a call to action

Farmer, P. E., Frenk, J. M., Knaul, F. M., Shulman, L. N., Alleyne, G. A. O., Armstrong, L., Atun, R. A., Blayney, D. W., Chen, L., Feachem, R. G., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61152-x · Cited by 797 · see citing works

Cost-Effectiveness of Cervical-Cancer Screening in Five Developing Countries

Goldie, S. J., Gaffikin, L., Goldhaber-Fiebert, J. D., Gordillo-Tobar, A., Levin, C., Mahé, C., & Wright, T. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa044278 · Cited by 666 · see citing works

Cancer survival in Africa, Asia, and Central America: a population-based study

Sankaranarayanan, R., Swaminathan, R., Brenner, H., Chen, K., Chia, K. S., Chen, J., Law, S. C., Ahn, Y., Xiang, Y., Yeole, B. B., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70335-3 · Cited by 617 · see citing works

Incidence, Duration, and Determinants of Cervical Human Papillomavirus Infection in a Cohort of Colombian Women with Normal Cytological Results

Muñóz, N., Méndez, F., Posso, H., Molano, M., van den Brule, A., Ronderos, M., Meijer, C. J. L. M., Muñoz, Á., & Instituto Nacional de Cancerología HPV study group (2004) · The Journal of Infectious Diseases · doi:10.1086/425907 · Cited by 393 · see citing works

Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study

Jit, M., Brisson, M., Portnoy, A., & Hutubessy, R. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70237-2 · Cited by 261 · see citing works

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

Naud, P., Roteli-Martins, C. M., de Carvalho, N. S., Teixeira, J. C., de Borba, P. C., Sánchez, N., Zahaf, T., Catteau, G., Geeraerts, B., & Descamps, D. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.29532 · Cited by 251 · see citing works

Radiation Therapy Infrastructure and Human Resources in Low- and Middle-Income Countries: Present Status and Projections for 2020

Datta, N. R., Samiei, M., & Bodis, S. B. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.03.002 · Cited by 234 · see citing works

Development assistance for health: past trends, associations, and the future of international financial flows for health

Dieleman, J. L., Schneider, M. T., Haakenstad, A., Singh, L., Sadat, N., Birger, M., Reynolds, A., Templin, T., Hamavid, H., Chapin, A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30168-4 · Cited by 234 · see citing works

Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries

Goldie, S. J., O'Shea, M., Campos, N. G., Diaz, M., Sweet, S., & Kim, S.-Y. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.04.053 · Cited by 197 · see citing works

Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule

Romanowski, B., Schwarz, T. F., Ferguson, L. M., Peters, K., Dionne, M., Schulze, K., Ramjattan, B., Hillemanns, P., Catteau, G., Dobbelaere, K., et al. (2011) · Human Vaccines · doi:10.4161/hv.7.12.18322 · Cited by 193 · see citing works

Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women

Carvalho, N. D., Teixeira, J. C., Roteli-Martins, C. M., Naud, P., Borba, P. D., Zahaf, T., Sanchez, N. R., & Schuind, A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.007 · Cited by 169 · see citing works

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

Herrero, R., Hildesheim, A., Rodríguez, A. C., Wacholder, S., Bratti, C., Solomon, D., González, P., Porras, C., Jiménez, S., Guillén, D., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.002 · Cited by 169 · see citing works

Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study

Ginsberg, G. M., Lauer, J. A., Zelle, S. G., Baeten, S. A., & Baltussen, R. M. P. M. (2012) · BMJ · doi:10.1136/bmj.e614 · Cited by 139 · see citing works

An updated natural history model of cervical cancer: derivation of model parameters

Campos, N. G., Burger, E. A., Sy, S., Sharma, M., Schiffman, M., Rodriguez, A. C., Hildesheim, A., Herrero, R., & Kim, J. J. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu159 · Cited by 116 · see citing works

Cancer Survival in Africa, Asia, the Caribbean and Central America

Sankaranarayanan, R., & Swaminathan, R. (2000) · Medical Entomology and Zoology · Cited by 82 · see citing works

Cervical cancer screening in low‐resource settings: A cost‐effectiveness framework for valuing tradeoffs between test performance and program coverage

Campos, N. G., Castle, P. E., Wright, T. C., & Kim, J. J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29594 · Cited by 71 · see citing works

When and how often to screen for cervical cancer in three low- and middle-income countries: a cost-effectiveness analysis

Campos, N. G., Tsu, V., Jeronimo, J., Mvundura, M., Lee, K., & Kim, J. J. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.05.003 · Cited by 56 · see citing works

The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador

Campos, N. G., Maza, M., Alfaro, K. M., Gage, J. C., Castle, P. E., Felix, J. C., Cremer, M., & Kim, J. J. (2015) · International Journal of Cancer · doi:10.1002/ijc.29438 · Cited by 54 · see citing works

Resources Required for Cervical Cancer Prevention in Low- and Middle-Income Countries

Campos, N. G., Sharma, M., Clark, A. D., Kim, J. J., & Resch, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164000 · Cited by 41 · see citing works

To expand coverage, or increase frequency: Quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings

Campos, N. G., Tsu, V. D., Jerónimo, J., Mvundura, M., Lee, K., & Kim, J. J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30551 · Cited by 40 · see citing works

In Reply to Sharma et al

Datta, N. R., Samiei, M., & Bodis, S. B. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.07.036 · Cited by 8 · see citing works

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · see citing works

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Brisson, M., Kim, J. J., Canfell, K., Drolet, M., Gingras, G., Burger, E. A., Martin, D., Simms, K. T., Bénard, É., Boily, M.-C., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30068-4 · Cited by 943 · see citing works

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

Canfell, K., Kim, J. J., Brisson, M., Keane, A., Simms, K. T., Caruana, M., Burger, E. A., Martin, D., Nguyen, D. T. N., Bénard, É., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30157-4 · Cited by 650 · see citing works

Adding It Up: Investing in Sexual and Reproductive Health 2019

Sully, E., Biddlecom, A., Darroch, J. E., Riley, T., Ashford, L. S., Lince-Deroche, N., Firestein, L., & Murro, R. (2020) · doi:10.1363/2020.31593 · Cited by 415 · see citing works

Lifetime Prevalence of Cervical Cancer Screening in 55 Low- and Middle-Income Countries

Lemp, J. M., De Neve, J.-W., Bussmann, H., Chen, S., Manne-Goehler, J., Theilmann, M., Marcus, M.-E., Ebert, C., Probst, C., Tsabedze-Sibanyoni, L., et al. (2020) · JAMA · doi:10.1001/jama.2020.16244 · Cited by 190 · see citing works

Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis

Iragorri, N., & Spackman, E. (2018) · Public health reviews · doi:10.1186/s40985-018-0093-8 · Cited by 142 · see citing works

Towards adult vaccination in India: a narrative literature review

Dash, R., Agrawal, A. K., Nagvekar, V. C., Lele, J., Pasquale, A. D., Kolhapure, S., & Parikh, R. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1682842 · Cited by 64 · see citing works

Lightweight convolutional neural network with knowledge distillation for cervical cells classification

Chen, W., Gao, L., Li, X., & Shen, W. (2021) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2021.103177 · Cited by 63 · see citing works

Transforming vaccine development

BLACK, S. B., Bloom, D. E., Kaslow, D. C., Pecetta, S., & Rappuoli, R. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101413 · Cited by 55 · see citing works

HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it

Nogueira‐Rodrigues, A., Flores, M. G., Neto, A. O. M., Braga, L. A. C., Vieira, C. M., de Sousa-Lima, R. M., de Andrade, D. A. P., Machado, K. K., & Guimarães, A. P. G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.984449 · Cited by 48 · see citing works

Cancer in Africa: Is It a Genetic or Environmental Health Problem?

Bahnassy, A. A., Abdellateif, M. S., & Zekri, A. N. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.604214 · Cited by 44 · see citing works

Global human papilloma virus vaccine implementation: An update

Sabeena, S., Bhat, P. V., Kamath, V. G., & Arunkumar, G. (2018) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.13634 · Cited by 41 · see citing works

Impact of knowledge and attitude on the utilization rate of cervical cancer screening tests among Ethiopian women: A systematic review and meta-analysis

Kassie, A. M., Abate, B. B., Kassaw, M. W., Aragie, T. G., Geleta, B. A., & Shiferaw, W. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0239927 · Cited by 43 · see citing works

A systematic review of the barriers to implementing human papillomavirus vaccination programs in low‐ and middle‐income countries in the Asia‐Pacific

Ver, A. T., Notarte, K. I., Velasco, J. V., Buac, K. M., Nazareno, J., Lozañes, J. A., Antonio, D., & Bacorro, W. (2021) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13513 · Cited by 39 · see citing works

A comparison of behavioural models explaining cervical cancer screening uptake

Dsouza, J. P., den Broucke, S. V., Pattanshetty, S. M., & D’Hoore, W. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01801-2 · Cited by 38 · see citing works

Segmentation and Classification Techniques for Pap Smear Images in Detecting Cervical Cancer: A Systematic Review

Wubineh, B. Z., Rusiecki, A., & Halawa, K. (2024) · IEEE Access · doi:10.1109/access.2024.3447887 · Cited by 52 · see citing works

Cervical Cancer as a Global Concern

Chibwesha, C. J., & Stringer, J. S. A. (2019) · JAMA · doi:10.1001/jama.2019.16176 · Cited by 33 · see citing works

Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea

Nguyen, D., Simms, K. T., Keane, A., Mola, G., Bolnga, J. W., Kuk, J., Toliman, P. J., Badman, S. G., Saville, M., Kaldor, J. M., et al. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2021-007380 · Cited by 33 · see citing works

HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis

Mekuria, S. F., Timmermans, S., Borgfeldt, C., Jerkeman, M., Johansson, P., & Linde, D. S. (2023) · Systematic Reviews · doi:10.1186/s13643-023-02252-y · Cited by 32 · see citing works

Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening

Boily, M., Barnabas, R. V., Rönn, M. M., Broshkevitch, C. J., van Schalkwyk, C., Soni, N., Rao, D. W., Staadegaard, L., Liu, G., Silhol, R., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101754 · Cited by 32 · see citing works

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries

Ochalek, J., Abbas, K., Claxton, K., Jit, M., & Lomas, J. R. S. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2020-003006 · Cited by 30 · see citing works

Analyzing the performance of ChatGPT in answering inquiries about cervical cancer

Yurtçu, E., Ozvural, S., & Keyif, B. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15861 · Cited by 24 · see citing works

Cervical cancer prevention in Africa: A policy analysis

Akanda, R., Kawale, P., & Moucheraud, C. (2022) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2021.100321 · Cited by 23 · see citing works

The investment case for cervical cancer elimination

Tsu, V. D., & Ginsburg, O. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12193 · Cited by 23 · see citing works

Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan

Anwari, P., Debellut, F., Vodicka, E. L., Clark, A. D., Farewar, F., Zhwak, Z. A., Nazary, D., Pecenka, C. J., LaMontagne, D. S., & Safi, N. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.12.013 · Cited by 19 · see citing works

Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia

Antinyan, A., Bertoni, M., & Corazzini, L. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.113739 · Cited by 18 · see citing works

Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis

Campos, N. G., Tsu, V. D., Jerónimo, J., Regan, C., Resch, S., Clark, A. D., Sy, S., & Kim, J. J. (2018) · International Journal of Cancer · doi:10.1002/ijc.31823 · Cited by 17 · see citing works

Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study

Guimarães, E. L., Chissaque, A., Pecenka, C. J., Debellut, F., Schuind, A., Vaz, B., Banze, A., Rangeiro, R., Mariano, A. A. N., Lorenzoni, C. F., et al. (2023) · Vaccines · doi:10.3390/vaccines11061058 · Cited by 15 · see citing works

A guide to global access to HPV vaccination to all women in low- and middle-income countries; a minireview of innovation and equity

Ewongwo, A. N., Sahor, A. F., Ngwa, W. F., & Nwachukwu, C. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1380663 · Cited by 15 · see citing works

Community-based household assessment of human papillomavirus (HPV) vaccination coverage and acceptability – HPV vaccine demonstration program, Cambodia – 2017

Garon, J. R., Vong, W. I., Sreenivasan, N., Wannemuehler, K. A., Vutthikol, Y., Chhea, C., & Loharikar, A. R. (2019) · Vaccine · doi:10.1016/j.vaccine.2018.12.052 · Cited by 15 · see citing works

Socioeconomic inequalities in cervical precancer screening among women in Ethiopia, Malawi, Rwanda, Tanzania, Zambia and Zimbabwe: analysis of Population-Based HIV Impact Assessment surveys

Chipanta, D., Kapambwe, S. K., Mipando, A. L. N., Pascoe, M. J., Amo-Agyei, S., Bohlius, J., Estill, J. A. M., & Keiser, O. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-067948 · Cited by 14 · see citing works

Progress and challenges in human papillomavirus and cervical cancer in southern Africa

Ramogola‐Masire, D., Luckett, R. L., & Dreyer, G. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000805 · Cited by 13 · see citing works

‘I’m here to save my life’: a qualitative study of experiences navigating a cryotherapy referral system for human papillomavirus-positive women in western Kenya

Huchko, M. J., Adewumi, K., Oketch, S. Y., Ibrahim, S., & Bukusi, E. A. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-028669 · Cited by 13 · see citing works

Oral Cancer Disparities in Low‑ and Middle‑Income Countries: A Global Health Equity Perspective on Prevention, Early Detection, and Treatment Access

Francis, D. L., & Reddy, S. S. P. (2025) · Annals of Global Health · doi:10.5334/aogh.5003 · Cited by 12 · see citing works

Systematic literature review of primary and secondary cervical cancer prevention programs in South America

Gomes, M. L. D. S., Moura, N. D. S., Magalhães, L. D. C., da Silva, R. R., Silva, B. G. S., Rodrigues, I. R., Sales, L. B. F., & Oriá, M. O. B. (2023) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2023.96 · Cited by 12 · see citing works

Health gains and financial protection from human papillomavirus vaccination in Ethiopia: findings from a modelling study

Portnoy, A., Sweet, S., Desalegn, D., Memirie, S. T., Kim, J. J., & Verguet, S. (2021) · Health Policy and Planning · doi:10.1093/heapol/czab052 · Cited by 12 · see citing works

Comparative assessment of test characteristics of cervical cancer screening methods for implementation in low-resource settings

Asgary, R. G., Beideck, E., & Naderi, R. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106883 · Cited by 12 · see citing works

Perception of Women’s Knowledge of and Attitudes towards Cervical Cancer and Papanicolaou Smear Screenings: A Qualitative Study in South Africa

Gwavu, Z., Murray, D., & Okafor, U. B. (2023) · Healthcare · doi:10.3390/healthcare11142089 · Cited by 11 · see citing works

Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015

Pikala, M., Burzyńska, M., & Maniecka‐Bryła, I. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16091545 · Cited by 11 · see citing works

Response of Bangladesh to the World Health Organization call to eliminate cervical cancer as a public health issue: An observational report

Reza, S., Dewan, S. M. R., Islam, M. S., & Shahriar, M. (2024) · Health Science Reports · doi:10.1002/hsr2.2178 · Cited by 10 · see citing works

Recommendations for the prevention, screening, diagnosis, staging, and management of cervical cancer in areas with limited resources: Report from the International Gynecological Cancer Society consensus meeting

Maluf, F. C., Molin, G. Z. D., de Melo, A. C., Paulino, E., Racy, D. J., Ferrigno, R., Usón, P. L. S., Ribeiro, R., Moretti‐Marques, R., Sadalla, J. C., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.928560 · Cited by 10 · see citing works

Comprehensive Approach to Costing Cervical Cancer Prevention and Control: A Case Study in the United Republic of Tanzania Using the Cervical Cancer Prevention and Control Costing (C4P) Tool

Levin, A., Yuma, S., Swai, E., Morgan, W., Gauvreau, C. L., Broutet, N. J. N., Yeung, K. H. T., & Hutubessy, R. C. W. (2022) · BMC Medicine · doi:10.1186/s12916-022-02576-x · Cited by 10 · see citing works

A Comparison of the National Cervical Cancer Policies in Six Developing Countries with the World Health Organization Recommendations: A Narrative Review

Amir, S. M., Idris, I. B., Said, Z. M., Yusoff, H. M., & Manaf, M. R. A. (2023) · Iranian Journal of Public Health · doi:10.18502/ijph.v52i6.12952 · Cited by 8 · see citing works

Phytochemicals in Cervical Cancer: An Epigenetic Overview

El-Zeiny, N., Shafei, A., Wagih, S., Saad, M., Abdelrahim, D. S., Salem, E. Y., Wael, M., Ellackany, R., & Matboli, M. (2023) · Epigenomics · doi:10.2217/epi-2023-0181 · Cited by 8 · see citing works

Unrevealing Lithium Repositioning in the Hallmarks of Cancer: Effects of Lithium Salts (LiCl and Li2CO3) in an In Vitro Cervical Cancer Model

García-Acosta, J. C., Castillo-Montoya, A. I., Rostro-Alonso, G. O., Villegas‐Vázquez, E. Y., Granados, L. I. Q., Sánchez‐Sánchez, L., López‐Muñoz, H., Cariño‐Calvo, L., López-Reyes, I., Bustamante-Montes, L. P., et al. (2024) · Molecules · doi:10.3390/molecules29184476 · Cited by 8 · see citing works

Uptake and determinants of cervical cancer prevention services among female college students in Kenya: A cross-sectional surveyPreprint

Ngetich, E., Nzisa, I., & Osoti, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.04.076513 · Cited by 8 · see citing works

Barriers and Facilitators to the Preadoption of a Computer-Aided Diagnosis Tool for Cervical Cancer: Qualitative Study on Health Care Providers’ Perspectives in Western Cameroon

Cattin, M., Datchoua, A. M., Yakam, V. F., Kenfack, B., Petignat, P., Thiran, J., Schönenberger, K., & Schmidt, N. C. (2024) · JMIR Cancer · doi:10.2196/50124 · Cited by 7 · see citing works

The distribution and pathogenic risk of non‐9‐valent vaccine covered HPV subtypes in cervical lesions

Ma, M., Zhu, J., Yang, Y., Wang, X., Jin, Y., Zhang, J., & Wu, S. (2022) · Cancer Medicine · doi:10.1002/cam4.4532 · Cited by 7 · see citing works

Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment

Herrick, T. M., Thomson, K. A., Shin, M., Gannon, S., Tsu, V. D., & de Sanjosé, S. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08423-2 · Cited by 7 · see citing works

Construction of an immune-related ceRNA network in cervical cancer based on HPV E6 splicing

Jiang, S., Zhou, Y., Ye, M., Li, X., Zhang, L., & Yang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.979884 · Cited by 7 · see citing works

Cervical cancer prevention for all women: Why now?

Tsu, V. D. (2017) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12188 · Cited by 6 · see citing works

A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination

Campos, N. G., Lowy, D. R., de Sanjosé, S., & SCHIFFMAN, M. H. (2024) · JNCI Monographs · doi:10.1093/jncimonographs/lgae040 · Cited by 8 · see citing works

Increased production and comprehensive guidelines needed for HPV vaccine

Phumaphi, J., Gautam, K. C., & Mason, E. M. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32976-9 · Cited by 5 · see citing works

Advancing the elimination of cervical cancer across Africa

Osafo, K. S., Zhang, Y., Obiri-Yeboah, D., Sun, B., Yang, H., & Sun, P. (2026) · Nature Communications · doi:10.1038/s41467-026-70450-y · Cited by 4 · see citing works

A prospective model of the potential clinical and economic impact of cervical cancer screening supported by a mobile phone app

Asirwa, F. C., Bresnahan, B. W., Yego, F., Duncan, D., Karichu, J. K., & Garrison, L. P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0316001 · Cited by 3 · see citing works

Assessment of Awareness and Acceptance of the Human Papillomavirus Vaccine among Women in Saudi Arabia: A Community-Based Survey

Alrashidi, M. M., Ali, A. K., Miskeen, E., Algarni, A. D., Almatrafi, R. S., Albudyri, N. S., & Alrashidi, T. A. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5111258 · Cited by 2 · see citing works

Overcoming drug resistance in cervical cancer: Chemosensitizing agents and targeted therapies

Jalil, A., Wert, J., Farooq, A., & Ahmad, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824299-5.00010-1 · Cited by 2 · see citing works

Cervical Cancer Screening Practice and Associated Factors Among School Teachers in Bahir Dar City, North West Ethiopia: A Cross‐Sectional Study

Nega, B. G., Yadita, Z. S., Misker, A. D., Ebrahim, A. B., & Asresie, M. B. (2024) · Health Science Reports · doi:10.1002/hsr2.70295 · Cited by 2 · see citing works

Knowledge, attitudes, and practices regarding HPV infection, cervical cancer, and HPV vaccination among Emirati women

Sozib, M. S. I., Smail, L., & Jassim, G. (2025) · Future Oncology · doi:10.1080/14796694.2025.2575519 · Cited by 1 · see citing works

A global care package for women: Gender‐neutral human papillomavirus eradication

Ueda, S. M., & Temkin, S. M. (2020) · Cancer · doi:10.1002/cncr.33115 · Cited by 1 · see citing works

Knowledge, Sexual Behaviors on Human Papillomavirus Infections and Associated Factors: Survey Among Female Adolescents and Adults in the Republic of Congo

Nkounkou, R. B. B., Essangui, E., Foko, L. P. K., Nganga, C. P., Tsimba, P. C. L., Ntsiba, A. M. N., Boumba, L. M. A., Niama, F. R., & Moukoko, C. E. E. (2023) · Cancer Research Journal · doi:10.11648/j.crj.20231102.14 · Cited by 1 · see citing works

Trends in Mortality Due to Malignant Neoplasms of Female Genital Organs in Poland in the Period 2000–2021—A Population-Based Study

Pikala, M., & Burzyńska, M. (2024) · Cancers · doi:10.3390/cancers16051038 · Cited by 1 · see citing works

Socioeconomic inequalities in cervical pre-cancer screening among women in Ethiopia, Malawi, Rwanda, Tanzania, Zambia, and Zimbabwe – Analysis of Population-Based HIV Impact Assessment surveysPreprint

Chipanta, D., Kapambwe, S. K., Mipando, A. L. N., Pascoe, M. J., Amo-Agyei, S., Bohlius, J., Estill, J. A. M., & Keiser, O. (2022) · Research Square · doi:10.21203/rs.3.rs-1395417/v1 · Cited by 1 · see citing works

Preventive Phytochemicals of Cancer, as Speed Breakers in Inflammatory Signaling

Adetuyi, B. O., Olajide, P. A., Adetuyi, O. A., & Oloke, J. K. (2022) · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences · doi:10.26479/2022.0801.03

Perceptions and attitudes toward partners support for cervical cancer screening among married men in Ghana

Osei, E. A., Bakkari, M. A., Boateng, S. A., Acquah, A., Menlah, A., Adusei, A. B., Kumah, J., & Sekyi, E. (2023) · Public Health · doi:10.1016/j.puhe.2023.07.024

Методология и эффективность скрининга рака шейки матки в мировой практике

Тер-Минасян, В. А. (2023) · Armenian Journal of Health & Medical Sciences · doi:10.54235/27382737-2023.v3.2-36

Harnessing the law to advance equitable cancer care in South Africa: exploring the feasibility, desirability and added value of a dedicated national cancer act

Meyer, S., Harries, J., Torode, J., & Baldwin-Ragaven, L. (2024) · ecancermedicalscience · doi:10.3332/ecancer.2024.1658

Cervical cancer mortality trend in Montenegro—1990–2018

Vuković, M. N., Labovic, S. B., Jakšić, M., Vučković, L., & Vujović, A. (2025) · European Journal of Public Health · doi:10.1093/eurpub/ckaf059

Women’s Unique Health Needs and the Sustainable Development Goals: A Meeting Report from the 79th United Nations General Assembly Science Summit

Aninye, I. O., Chew, S., Althaus, N., Barry, M., Cheng, R.-F. J., Harris, C., Nwadinobi, E. A., Battaglino, B., Brooks, A. K., Guinen, J., et al. (2025) · Journal of Women s Health · doi:10.1177/15409996251377432

Stigma to Screening: Generative AI and Selfsampling Tools to Expand Cervical Cancer Screening in Low- and Middle-Income Countries

Rwasoka, L., Kramp, J., & Mehta, K. (2025) · IEEE Global Humanitarian Technology Conference (GHTC) · doi:10.1109/ghtc66843.2025.11266014

Costing Cervical Cancer Screening and Treatment Pathways: Case Studies in Bangladesh and Uganda

Sultanov, M., Pan, F., Nazrul, N., Rahman, A., Kabukye, J. K., Nakisige, C., de Zeeuw, J., van der Schans, J., Koot, J. A. R., de Bock, G. H., et al. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101566

Evaluation of rotavirus, pneumococcal conjugate and human papillomavirus vaccination in four Pacific island countries: A cost-effectiveness modelling study

Carvalho, N., Watts, E., Oliver, V., Clark, A. D., Ozturk, M. H., ‘Akau’ola, S., Whelan, C., Naseri, T., Jenkins, K., Mikkelsen-Lopez, I., et al. (2026) · PLoS Medicine · doi:10.1371/journal.pmed.1004604

Knowledge, attitudes, and practices of cervical cancer preventive services among mothers living with HIV in Lagos, Nigeria: a cross-sectional study

Jia, M. M., Wapmuk, A., Gbaja-Biamila, T. A., Abudulrasheed, O. A., Blessing, L. A., Tucker, J. D., & Ezechi, O. (2026) · BMC Public Health · doi:10.1186/s12889-026-27320-5

Knowledge, Awareness, Attitudes, and HPV Vaccine Uptake Among Women in the United Arab Emirates

Smail, L. (2026) · Women s Reproductive Health · doi:10.1080/23293691.2026.2679992

Living With Loss: The Caregiver Journey and Unmet Needs Across the Cervical Cancer Care Continuum in India

Kataria, I., Jose, S., Jebaraj, P., Kumar, R., Ramamoorthy, R., Sangeetha Rathnam, K., Nyblade, L. C., & Paul, B. (2026) · JCO Global Oncology · doi:10.1200/go-26-00031

Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru

Goldie, S. J., Levin, C., Mosqueira-Lovón, N. R., Ortendahl, J. D., Kim, J., O'Shea, M. K. H., Díaz, M., & Araujo, M. A. M. (2012) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892012001300006 · Cited by 23 · see citing works

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India

Diaz, M., Kim, J. J., Albero, G., de Sanjosé, S., Clifford, G., Bosch, F. X., & Goldie, S. J. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604462 · Cited by 132 · see citing works

Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review

Okeah, B. O., & Ridyard, C. H. (2020) · Applied Health Economics and Health Policy · doi:10.1007/s40258-020-00576-7 · Cited by 13 · see citing works

Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in Peru Repercusiones sanitarias y económicas de la vacunación de niñas preadolescentes contra los tipos 16 y 18 del virus del papiloma humano y el tamizaje del cáncer cervicouterino en las mujeres adultas en el Perú

Goldie, S. J., Levin, C., Mosqueira-Lovón, N. R., Ortendahl, J. D., Kim, J. J., O'Shea, M. K. H., Díaz, M., & Araujo, M. A. M. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)

Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa

Campos, N. G., Kim, J. J., Castle, P. E., Ortendahl, J. D., O'Shea, M. K. H., Díaz, M., & Goldie, S. J. (2011) · International Journal of Cancer · doi:10.1002/ijc.26269 · Cited by 95 · see citing works